A genome-wide approach to identifying novel-imprinted genes
- 436 Downloads
Genomic imprinting is an epigenetic process in which the copy of a gene inherited from one parent (maternal or paternal) is consistently silenced or expressed at a significantly lower level than the copy from the other parent. In an effort to begin a systematic genome-wide screen for imprinted genes, we assayed differential allelic expression (DAE) at 3,877 bi-allelic protein-coding sites located in 2,625 human genes in 67 unrelated individuals using genotyping microarrays. We used the presence of both over- and under-expression of the reference allele compared to the alternate allele to identify candidate-imprinted genes. We found 61 genes with at least twofold DAE plus “flipping” of the more highly expressed allele between reference and alternate across heterozygous samples. Sixteen flipping genes were genotyped and assayed for DAE in an independent data set of lymphoblastoid cell lines from two CEPH pedigrees. We confirmed that PEG10 is paternally expressed, identified one gene (ZNF331) with multiple lines of data indicating it is imprinted, and predicted several additional imprinting candidate genes. Our findings suggest that there are at most several hundred genes in the human genome that are universally imprinted. With samples of mRNA from appropriate tissues and a collection of informative cSNPs, a genome-wide search using this methodology could expand the list of genes that undergo genomic imprinting in a tissue- or temporal-specific manner.
KeywordsImprint Gene CEPH Heterozygous Individual Pedigree Analysis Reference Allele
At Perlegen Sciences we thank Erica J. Beilharz for project management assistance, Geoff B. Nilsen for designing the high-density array, and P.V. Pant for assistance with data analysis. At McGill University we thank Scott Gurd for technical assistance, Tomi M. Pastinen for supporting the osteoblast work and helpful discussions, and Olof Nilsson at Uppsala University, Sweden for collecting the bone samples for the osteoblast panel. T.J. Hudson is the recipient of a Clinician-Scientist Award in Translational Research by the Burroughs Wellcome Fund. This work was supported by an NHGRI grant to K.A. Frazer and by Genome Canada and Genome Quebec grants to T.J. Hudson. K.A. Frazer is a former employee of Perlegen Sciences, Inc.
- Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289–300Google Scholar
- Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N, Arima T, Wake N, Kamimura K, Satomura K, Hermann R, Bonthron DT, Hayashizaki Y (2000) The cell cycle control gene ZAC/PLAGL1 is imprinted—a strong candidate gene for transient neonatal diabetes. Hum Mol Genet 9:453–460PubMedCrossRefGoogle Scholar
- Nikaido I, Saito C, Mizuno Y, Meguro M, Bono H, Kadomura M, Kono T, Morris GA, Lyons PA, Oshimura M, RIKEN GER Group, GSL Members, Hayashizaki Y, Okazaki Y (2003) Discovery of imprinted transcripts in the mouse transcriptome using large-scale expression profiling. Genome Res 13:1402–1409PubMedCrossRefGoogle Scholar
- Pastinen T, Sladek R, Gurd S, Sammak A, Ge B, Lepage P, Lavergne K, Villeneuve A, Gaudin T, Brandstrom H, Beck A, Verner A, Kingsley J, Harmsen E, Labuda D, Morgan K, Vohl MC, Naumova AK, Sinnett D, Hudson TJ (2004) A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics 16:184–193PubMedGoogle Scholar